Proteins are kind of natural molecules that show unique functionalities and properties in biological materials and manufacturing field. There are numerous nanomaterials which are derived from protein, albumin, and gelatine. These nanoparticles have promising properties like biodegradability, no antigenicity, metabolizable, surface modifier, greater stability during in vivo during storage, and being relatively easy to prepare and monitor the size of the particles. These particles have the ability to attach covalently with drug and ligands. Protein nanoparticles can be used in various targeted therapies, namely, pulmonary delivery, cancer therapy, tumour therapy, and vaccines, in which protein nanoparticles can be incorporated into biodegradable polymer in the form of microspheres for controlled and sustained release. The major aim in designing nanoparticle as a drug delivery system is to control particle size, surface area, and surface properties so that the nanoparticles carrying required amount of drug show desired pharmacological activity by releasing actives in order to achieve site-specific action. Proteins nanoparticles have certain unique functionalities and potential applications in both biomedical and material sciences. They are recommended as ideal material for the preparation of nanoparticles because of their amphiphilicity which allow the nanoparticles to interact with both the drug and solvent. Nanoparticles derived from natural proteins are biodegradable, metabolizable, and easily adaptable to surface modifications to allow attachment of drug and targeting ligands. They can be synthesized from various protein including water soluble proteins.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation